The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
Showers will persist in the north but it should remain dry elsewhere with cloudy skies.
Scientists at Cardiff University hope to create a "super mead" using a mixture of herbs that can tackle salmonella.
A drug dealer driving a speeding car jumped out of the vehicle while it was moving in an attempt to escape the police chase.